Zeptide Injection 5 mg/0.5 ml is an advanced, once-weekly injectable antidiabetic medication containing Tirzepatide, a novel dual incretin receptor agonist used for the management of type 2 diabetes mellitus. Tirzepatide uniquely activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, delivering enhanced glycemic control along with beneficial effects on body weight and metabolic health.

Type 2 diabetes is characterized by insulin resistance, impaired insulin secretion, and inappropriate glucagon release. Zeptide Injection addresses these underlying defects by stimulating insulin secretion in a glucose-dependent manner, reducing glucagon levels, slowing gastric emptying, and decreasing appetite. These combined mechanisms help maintain stable blood glucose levels throughout the day and support meaningful weight reduction, which is an important component of comprehensive diabetes care.

The 5 mg strength is generally prescribed after successful initiation with a lower dose, allowing patients to achieve stronger glycemic control while maintaining tolerability. Its once-weekly dosing schedule improves treatment adherence and simplifies long-term diabetes management.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features

Indications

Zeptide Injection 5 mg/0.5 ml is indicated for:

• Treatment of type 2 diabetes mellitus in adults

• Improvement of glycemic control as an adjunct to diet and exercise

• Weight management support in overweight or obese patients with type 2 diabetes

• Use as monotherapy or combination therapy with other antidiabetic agents, including metformin or insulin, as advised by a healthcare professional

Active Ingredient

• Tirzepatide 5 mg per 0.5 ml

Tirzepatide’s dual GIP and GLP-1 receptor agonism provides broader metabolic benefits compared to traditional incretin therapies.

Benefits

• Dual Incretin Action: Enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner.

• Improved Glycemic Control: Effectively lowers both fasting and postprandial blood glucose levels.

• Supports Weight Reduction: Helps reduce appetite and caloric intake.

• Once-Weekly Administration: Convenient dosing improves patient compliance.

• Lower Hypoglycemia Risk: Minimal risk when used appropriately without insulin or sulfonylureas.

Dosage and Administration

• Route: Subcutaneous injection

• Frequency: Once weekly on the same day each week

• Recommended Dose: 5 mg once weekly, as prescribed by a physician

The injection may be administered in the abdomen, thigh, or upper arm. Dose adjustments should be made gradually and under medical supervision. Zeptide Injection is not intended for use in type 1 diabetes mellitus or diabetic ketoacidosis.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

Precautions

• Use only under the guidance of a qualified healthcare professional.

• Caution is required in patients with a history of pancreatitis or severe gastrointestinal disorders.

• Not recommended for patients with known hypersensitivity to Tirzepatide.

• Use during pregnancy or breastfeeding should be evaluated by a physician.

Side Effects

• Common adverse effects include nausea, vomiting, diarrhea, decreased appetite, and abdominal discomfort.

• These effects are generally transient and tend to improve with continued therapy.

Storage

• Store refrigerated at 2°C to 8°C.

• Do not freeze.

• Protect from light.

• Keep out of reach of children.

Why Choose Zeptide Injection?

• Proven dual-action therapy for effective diabetes control

• Convenient once-weekly injectable formulation

• Supports both glycemic control and weight management

• Reliable quality and formulation from SK Pharma.